Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 234 participants.

Also called NCT07594301

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 234 participants (planned count) (from the registry)
Sponsor
  • Xiang Luo Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07594301
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07594301. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-19 (actual); primary completion 2028-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)
Condition
Acute Ischemic Stroke
Condition
Endovascular Thrombectomy
Condition
Minocycline
Condition
Posterior Circulation
Condition
Arterial Occlusion
Intervention (Drug)
Minocycline hydrochloride capsule
Intervention (Drug)
Placebo capsules of Minocycline hydrochloride capsules
Lead sponsor
Xiang Luo (class: other)

Record details

Record id
cardio:ct-nct07594301
Content hash
a7f3d2bf7b78f713df29631d9fdba32c5da39feef2c954456b71f8566052447a